Patent analysis in the Supreme Court - Warner-Lambert v Generics

POSTED BY ISABEL TEARE | ARCHIVE |
| 1 min read

Last week the Supreme Court gave its decision in a long-running pharmaceutical patent dispute between Warner-Lambert and Generics. The court analysed patent insufficiency as a basis for invalidity and the infringement of Swiss-form claims.

Although most relevant to the drugs industry, this ruling will also be of interest to other patent-heavy sectors. 

We discuss the analysis of insufficiency, and infringement on our sister blog Life Science Law.

Our content explained

Every piece of content we create is correct on the date it’s published but please don’t rely on it as legal advice. If you’d like to speak to us about your own legal requirements, please contact one of our expert lawyers.

Posted by

Tags

Search

Mills & Reeve Sites navigation
A tabbed collection of Mills & Reeve sites.
Sites
My Mills & Reeve navigation
Subscribe to, or manage your My Mills & Reeve account.
My M&R

Visitors

Register for My M&R to stay up-to-date with legal news and events, create brochures and bookmark pages.

Register
Visitor Login

Existing clients

Log in to your client extranet for free matter information, know-how and documents.

Client Extranet

Staff

Mills & Reeve system for employees.

Staff Login

Our use of cookies

To help improve your experience of our website we would like to use cookies. This means we collect some information on your activity while you are on the website. For more information read more about our use of cookies here, your setting can be changed at any time.
Please accept our use of cookies and help us improve your experience.

Accept Cookie settings
Close overlay